Telix Pharmaceuticals Forecast, price target & analysts
Telix Pharmaceuticals Target price 2025 - Analyst rating & recommendation
Telix Pharmaceuticals Classifications & Recommendation:
Telix Pharmaceuticals Price Target
| Target Price | A$27.23 |
| Price | A$15.39 |
| Potential |
76.96%
register free of charge
|
| Number of Estimates | 11 |
|
11 Analysts have issued a price target Telix Pharmaceuticals 2026 .
The average Telix Pharmaceuticals target price is A$27.23.
This is
76.96%
register free of charge
A$37.80
145.61%
register free of charge
A$22.22
44.38%
register free of charge
|
|
| A rating was issued by 16 analysts: 15 Analysts recommend Telix Pharmaceuticals to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Telix Pharmaceuticals stock has an average upside potential 2026 of
76.96%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million A$ | 512.53 | 1,093.00 |
| 55.85% | 113.26% | |
| Net Margin | 6.37% | 3.62% |
| 514.75% | 43.21% |
14 Analysts have issued a sales forecast Telix Pharmaceuticals 2025 . The average Telix Pharmaceuticals sales estimate is
This results in the following potential growth metrics:
14 Telix Pharmaceuticals Analysts have issued a net profit forecast 2025. The average Telix Pharmaceuticals net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share A$ | 0.09 | 0.12 |
| 800.00% | 33.33% | |
| P/E | 131.54 | |
| EV/Sales | 4.96 |
14 Analysts have issued a Telix Pharmaceuticals forecast for earnings per share. The average Telix Pharmaceuticals EPS is
This results in the following potential growth metrics and future valuations:
Telix Pharmaceuticals...
Current Telix Pharmaceuticals Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| WILSONS |
Locked
➜
Locked
|
Locked | Sep 16 2025 |
| JEFFERIES |
Locked
➜
Locked
|
Locked | Sep 08 2025 |
| BELL POTTER SECURITIES |
Locked
➜
Locked
|
Locked | Sep 04 2025 |
| WEDBUSH SECURITIES INC. |
Locked
➜
Locked
|
Locked | Aug 28 2025 |
| TD COWEN |
Locked
➜
Locked
|
Locked | Aug 28 2025 |
| WILSONS |
Locked
➜
Locked
|
Locked | Jul 18 2025 |
| WILSONS |
Locked
➜
Locked
|
Locked | Jul 17 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
WILSONS:
Locked
➜
Locked
|
Sep 16 2025 |
|
Locked
JEFFERIES:
Locked
➜
Locked
|
Sep 08 2025 |
|
Locked
BELL POTTER SECURITIES:
Locked
➜
Locked
|
Sep 04 2025 |
|
Locked
WEDBUSH SECURITIES INC.:
Locked
➜
Locked
|
Aug 28 2025 |
|
Locked
TD COWEN:
Locked
➜
Locked
|
Aug 28 2025 |
|
Locked
WILSONS:
Locked
➜
Locked
|
Jul 18 2025 |
|
Locked
WILSONS:
Locked
➜
Locked
|
Jul 17 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
